CN1196936A - Medicament for treating primary glomerular disease and its prepn. method - Google Patents
Medicament for treating primary glomerular disease and its prepn. method Download PDFInfo
- Publication number
- CN1196936A CN1196936A CN 97102778 CN97102778A CN1196936A CN 1196936 A CN1196936 A CN 1196936A CN 97102778 CN97102778 CN 97102778 CN 97102778 A CN97102778 A CN 97102778A CN 1196936 A CN1196936 A CN 1196936A
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- making
- medicament
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
A Chinese patent medicine for curing primary glomerular diseases with distinct curative effect is prepared from 10 Chinese-medicinal materials such as common three-wing nut root, acanthopanax bark, bupleurum root, scutellaria root, etc.
Description
The present invention relates to a kind of Chinese medicine preparation and pharmaceutical methods thereof for the treatment of primary glomerulopathy.
At present the medicament of treatment primary glomerulopathy roughly can be divided into two kinds in Chinese medicine and Western medicine, and the differential diagnosis in tcm opinion is controlled, except the acute nephritis curative effect better, then undesirable to the nephritis treatment effect of some other type; Western medicine is certain to some renal glomerular disease curative effect, but long-term the extensive application has significant side effects, and is also undesirable to the therapeutic effect of some type nephritis.
The objective of the invention is to develop a kind of have certain antibiotic, antiviral, antiallergic action and antiinflammatory; mediator's body immunity function; improve the glomerule hematodinamics, protect and recovery renal corpuscle proximal convoluted tubule cell function, primary glomerulopathy is had the Chinese medicine preparation of obvious curative effects.
First kind of prescription realizing purpose of the present invention is: Radix Tripterygii Wilfordii 4 restrains, Cortex Acanthopancis 5 restrains, Radix Bupleuri 5 restrains, Radix Scutellariae 3 restrains, Radix Rhapontici 5 restrains, cattle sunset 7 restrain, Radix Angelicae Sinensis 5 restrains, Radix Salviae Miltiorrhizae 8 restrains, Rhizoma Chuanxiong 4 restrains, Hirudo 0.5 restrains;
Method for making: 1. Hirudo porphyrize powder; 2. Radix Tripterygii Wilfordii (peeling) decocting is 2 hours, gets the filtrate concentrate drying; 3. all the other eight flavor medicine Hybrid Heating water extractions, the filtrate concentrate drying is mixed with Hirudo powder with 2. mixing pulverizing again, makes enteric coated tablet.This is a dose, and treatment latent nephritis day is obeyed secondary, 15 days one courses of treatment.
The treatment acute nephritis will add Flos Lonicerae 6 gram, Fructus Forsythiae 6 grams in first kind of prescription, eight water of distinguishing the flavor of in the medicines together that this two medicine adds are up carried, and all the other (comprising method for making etc.) are identical with first kind of prescription; This is a dose, obeys once in 8 hours, and 10 days is a course of treatment.
Treat radical nephritis and will add Flos Lonicerae 15 gram, Fructus Forsythiae 10 grams in first kind of prescription, this two medicine is added in the eight flavor medicines of first kind of prescription together water and carries, all the other (comprising method for making etc.) and first fill a prescription identical; This also is a dose, and 6 hours once, and 15 days is a course of treatment.
The treatment chronic nephritis is to add Radix Codonopsis 5 grams, Radix Astragali 10 grams in first kind of prescription, this two medicine is added in the eight flavor medicines of first kind of prescription together water and carries, and all the other (comprising method for making etc.) are identical with first kind of prescription; This also is a dose, day clothes secondary, one month one course of treatment.
The treatment nephrotic syndrome is to add Radix Codonopsis 5 grams, Radix Astragali 20 grams, Semen Cuscutae 10 grams in first kind of prescription, this three medicine is added in the eight flavor medicines of first kind of prescription together water and carries, and all the other (comprising method for making etc.) are identical with first kind of prescription; This also is a dose, day clothes secondary, one month one course of treatment.
Use above-mentioned each medicament to note: 1, acute nephritis is as hyperpyrexia, heart failure, hypertensive encephalopathy and primary glomerulopathy occurring, or acute and chronic renal failure etc. occurs, should handle to the ill.2, anemia of pregnant woman, menstrual phase women have bleeding tendency person to avoid usefulness.3, the careful usefulness of menorrheal usually women.
Advantage of the present invention is to have antibiotic, antiviral, antiallergic action and antiinflammatory, and mediator's body immunity function improves the glomerule hematodinamics, protection and recover renal corpuscle, and the proximal convoluted tubule cell function has obvious curative effects to primary glomerulopathy.
Embodiment one is 1.. water intaking trematodiasis 0.5 gram levigation; 2.. Radix Tripterygii Wilfordii (peeling) 4 grams, decocting 2 hours is got secondary filtrate concentrate drying; 3.. get Cortex Acanthopancis 5 gram, Radix Bupleuri 5 grams, Radix Scutellariae 3 grams, Radix Rhapontici 5 grams, cattle sunset 7 gram, Radix Angelicae Sinensis 5 grams, Radix Salviae Miltiorrhizae 8 grams, Rhizoma Chuanxiong 4 grams, this eight flavors medicine Hybrid Heating water is carried the filtrate concentrate drying; Will be 2., 3. mix to pulverize with 1. being mixed and make enteric coated tablet.
Embodiment two is basic identical with example one, just increases Flos Lonicerae 6 grams in 3., Fructus Forsythiae 6 grams, and all the other (comprising pharmaceutical methods etc.) are all identical with example one.
Embodiment three is basic identical with example one, just increases Flos Lonicerae 15 grams, Fructus Forsythiae 10 grams in 3., and all the other (comprising pharmaceutical methods etc.) are all identical with example one.
Embodiment four is basic identical with example one, just increases Radix Codonopsis 5 grams, Radix Astragali 10 grams in 3., and all the other (comprising pharmaceutical methods etc.) are all identical with example one.
Embodiment five and example one are basic identical, just increase Radix Codonopsis 5 grams in 3., and Radix Astragali 20 grams, Semen Cuscutae 10 restrain, all the other (comprising pharmaceutical methods etc.) are all identical with example one.
Claims (5)
1, the medicament and the method for making thereof of treatment primary glomerulopathy relate to a kind of Chinese medicine preparation and method for making thereof for the treatment of primary glomerulopathy, it is characterized in that getting Radix Tripterygii Wilfordii 4 gram, Cortex Acanthopancis 5 grams, Radix Bupleuri 5 grams, Radix Scutellariae 3 grams, Radix Rhapontici 5 grams, cattle sunset 7 gram, Radix Angelicae Sinensis 5 grams, Radix Salviae Miltiorrhizae 8 grams, Rhizoma Chuanxiong 4 grams, Hirudo 0.5 gram;
Method for making: 1.. Hirudo porphyrize powder; 2.. Radix Tripterygii Wilfordii (peeling) decocting 2 hours, get the filtrate concentrate drying; 3.. all the other eight flavor medicine Hybrid Heating water extractions, the filtrate concentrate drying is mixed with Hirudo powder with 2. mixing pulverizing again, makes enteric coated tablet.
2, according to the medicament and the method for making thereof of the said treatment primary glomerulopathy of claim 1, it is characterized in that in above-mentioned prescription, adding again Flos Lonicerae 6 grams, Fructus Forsythiae 6 grams, with this two medicine add said up eight the flavor medicines in together water carry, all the other (comprising method for making etc.) are identical with claim 1.
3, according to the medicament and the method for making thereof of the said treatment primary glomerulopathy of claim 1, it is characterized in that in prescription, adding again Flos Lonicerae 15 grams, Fructus Forsythiae 10 grams, with this two medicine be added in the claim 1 said eight the flavor medicines in together water carry, all the other (comprising method for making etc.) are identical with claim 1.
4, according to the medicament and the method for making thereof of the said treatment primary glomerulopathy of claim 1, it is characterized in that in prescription, adding again Radix Codonopsis 5 grams, Radix Astragali 10 grams, with this two medicine be added in the claim 1 said eight the flavor medicines in together water carry, all the other (comprising method for making etc.) are identical with claim 1.
5, according to the medicament and the method for making thereof of the said treatment primary glomerulopathy of claim 1, it is characterized in that in prescription, adding again Radix Codonopsis 5 grams, Radix Astragali 20 grams, Semen Cuscutae 10 grams, with this three medicine be added in the claim 1 said eight the flavor medicines in together water carry, all the other (comprising method for making etc.) are identical with claim 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97102778A CN1072939C (en) | 1997-04-18 | 1997-04-18 | Medicament for treating primary glomerular disease and its prepn. method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN97102778A CN1072939C (en) | 1997-04-18 | 1997-04-18 | Medicament for treating primary glomerular disease and its prepn. method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1196936A true CN1196936A (en) | 1998-10-28 |
| CN1072939C CN1072939C (en) | 2001-10-17 |
Family
ID=5166437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97102778A Expired - Fee Related CN1072939C (en) | 1997-04-18 | 1997-04-18 | Medicament for treating primary glomerular disease and its prepn. method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1072939C (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI467941B (en) * | 2007-03-14 | 2015-01-01 | Mks Instr Inc | Multipoint voltage and current probe system |
| CN104997852A (en) * | 2015-09-02 | 2015-10-28 | 济南知尔医药科技有限公司 | Traditional Chinese medicine composition for treating glandular cystitis |
| CN106963843A (en) * | 2017-04-20 | 2017-07-21 | 石家庄肾病医院股份有限公司 | Lift the Chinese medicine composition and its application method of human peripheral blood regulatory T cells |
-
1997
- 1997-04-18 CN CN97102778A patent/CN1072939C/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI467941B (en) * | 2007-03-14 | 2015-01-01 | Mks Instr Inc | Multipoint voltage and current probe system |
| CN104997852A (en) * | 2015-09-02 | 2015-10-28 | 济南知尔医药科技有限公司 | Traditional Chinese medicine composition for treating glandular cystitis |
| CN106963843A (en) * | 2017-04-20 | 2017-07-21 | 石家庄肾病医院股份有限公司 | Lift the Chinese medicine composition and its application method of human peripheral blood regulatory T cells |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1072939C (en) | 2001-10-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102755594B (en) | Traditional Chinese medicine composition for treating acute and chronic hepatitis B and preparation method thereof | |
| CN101380417B (en) | Preparation for quickly treating urticaria | |
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN1315525C (en) | Chinese traditional medicine for treating breast disease and preparing technique | |
| CN101095747A (en) | Chinese traditional medicine for treating various toothache | |
| CN103860699B (en) | A kind of pharmaceutical composition for effecting a radical cure three-hypers | |
| CN101569739B (en) | Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof | |
| CN101987138A (en) | Chinese medicinal preparation for treating impotence | |
| CN1332702C (en) | Medicine for treating psoriasis | |
| CN101518640A (en) | Chinese traditional medicine prescription for treating tumor | |
| CN1072939C (en) | Medicament for treating primary glomerular disease and its prepn. method | |
| CN1320914C (en) | Menstruation regulating powder | |
| CN101926903A (en) | Chinese medicine preparation for curing facial paralysis | |
| CN1056064C (en) | Medicine for curing liver cancer and its making method | |
| CN1332707C (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
| CN103055289B (en) | Traditional Chinese medicine composition for curing malignant lymphoma and preparation method thereof | |
| CN101856423A (en) | Medicament for treating menoxenia and preparation method thereof | |
| CN101181564A (en) | Chinese medicine compound preparations with antineoplastic activity | |
| CN101703645B (en) | Chinese medicinal composition for treating cervical vertebra hyperosteogeny | |
| CN100423769C (en) | Chinese medicine for treating coronary heart disease | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN102366594A (en) | Traditional Chinese medicine for adjusting menstruation | |
| CN102335243B (en) | Chinese medicinal composition for treating icteric hepatitis | |
| CN101693065A (en) | Medicament for treating polymyalgia rheumatica and preparation method thereof | |
| CN102085303A (en) | Traditional Chinese medicine composition for treating puerperal fever due to deficiency of blood |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |